Tradition Wealth Management’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-686
Closed -$4K 1294
2022
Q4
$4K Hold
686
﹤0.01% 1073
2022
Q3
$7K Hold
686
﹤0.01% 995
2022
Q2
$7K Hold
686
﹤0.01% 890
2022
Q1
$12K Sell
686
-349
-34% -$7.5K ﹤0.01% 845
2021
Q4
$32K Buy
1,035
+150
+17% +$4.97K ﹤0.01% 635
2021
Q3
$29K Buy
885
+342
+63% +$10.1K ﹤0.01% 643
2021
Q2
$16K Buy
+543
New +$15K ﹤0.01% 809

Other funds holding CKPT

Tradition Wealth Management's CKPT Position: Q1 2023 in Review

Tradition Wealth Management sold out of Checkpoint Therapeutics (CKPT) in Q1 2023, closing a stake of 686 shares — an estimated $4K sold.

Tradition Wealth Management first reported a position in CKPT in Q2 2021 and held it in 7 quarters. The position peaked at $32K in Q4 2021. 34 funds tracked by Wall St. Rank hold CKPT as of Q1 2023.

  • Tradition Wealth Management reported no remaining Checkpoint Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Tradition Wealth Management sold 686 Checkpoint Therapeutics shares in Q1 2023, an estimated $4K.
  • Tradition Wealth Management first reported a position in Checkpoint Therapeutics in Q2 2021 and held it in 7 quarters.
  • Tradition Wealth Management's Checkpoint Therapeutics position peaked at $32K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2023.

Based on Tradition Wealth Management's 13F filing for Q1 2023, filed 12 May 2023.